Hedge Funds, Schmedge Funds, It's A $3 Billion Offer

Oct 12, 2007

On the Wall Street Journal health blog, Jacob Goldstein discusses the "battle" for the diagnostic company Ventana -- Roche made a hostile bid for the company earlier this year. Goldstein reports that Roche's CEO, Franz Hume, has been saying that hedge funds have bought out the leading shareholders but that Roche's $3 billion offer will eventually go through.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Hold the GMO Mosquitoes

As the UN ponders a ban on gene drives, one malaria researchers says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

This Week in Nature

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.

Halt Under Consideration

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

How's It Going to Go Over?

The Associated Press reports that gene-edited food may soon be for sale.

Main menu